Tuesday, July 5, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

COVID-19-related hospitalizations in children below 18 years with influenza-associated hospitalizations

by Medical Finance
in Coronavirus
Study: Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States — FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021). Image Credit: Gorodenkoff/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A recent study posted to the medRxiv* preprint server compared coronavirus disease 2019 (COVID-19)-related hospitalizations in children below 18 years with influenza-associated hospitalizations.

Study: Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States — FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021). Image Credit: Gorodenkoff/Shutterstock
Study: Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States — FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021). Image Credit: Gorodenkoff/Shutterstock

Background

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza virus cause respiratory disorders, lead to severe disease, and even prove fatal in children. Vaccination against the influenza virus is annually recommended for children older than six months, whereas COVID-19 vaccination is approved only for those aged five years or more.

The hospitalization rate for influenza is the highest among the older population (≥ 65 years), followed by adults and children. Similarly, hospitalization due to SARS-CoV-2 infection is higher among adults than children. Nonetheless, data comparing the COVID-19 hospitalizations to influenza-associated hospitalizations in children are limited.

A comprehensive analysis comparing COVID-19- and flu-associated hospitalizations among children could help evaluate mitigation measures and interpret disease burden measures, which could guide the COVID-19 vaccination policy for children aged five years or less.

The study

In the present study, researchers compared the clinical characteristics, outcomes, and hospitalization rates in children (< 18 years) diagnosed with COVID-19 or seasonal flu in the United States (US).

The influenza hospitalization surveillance network (FluSurv-NET) conducts population-based surveillance of flu-associated hospitalizations during each season of influenza (October – April). The COVID-19-associated hospitalization surveillance network (COVID-NET) started similar surveillance in March 2020.

FluSurv-NET surveillance covered people from 14 states with a catchment population of 29 million people during the 2017-18 – 2020-21 seasons. COVID-NET conducted surveillance in all counties as FluSurv-NET with a catchment population of 32 million. A COVID-NET or FluSurv-NET case was defined as any hospitalized patient in the catchment area, as mentioned earlier, with positive influenza or SARS-CoV-2 test during or <14 days before hospitalization.

Hospitalized patients’ data on demography, clinical characteristics, clinical interventions like mechanical ventilation or extracorporeal membrane oxygenation, and outcomes such as pneumonia or intensive care unit (ICU) admission or in situ death were obtained by medical record abstractions. Hospitalizations were enumerated monthly for influenza seasons between October 2017 and April 2021 and COVID-19 from March 2020 to September 2021. The COVID-19 hospitalization rate was calculated for one year between October 1, 2020, and September 30, 2021, and compared with influenza. Seasonal hospitalization rates of influenza represented annual figures.

Results

Throughout the 2017-18 – 2019-20 seasons, 6774 children were hospitalized with flu, and 3461 were hospitalized with COVID-19 from October 2020 to September 2021. The median age of hospitalized children was three years for influenza compared to 9 years for COVID-19. Nearly 97% of children with flu presented at least one symptom at the time of admission, while 79.7% of COVID-19 cases developed one symptom at least. More than 55% of influenza cases and >53% COVID-19 cases had one underlying medical condition, with asthma, neurologic disorders, and obesity being the most prevalent conditions for flu and COVID-19 patients.

The authors observed a typical seasonal pattern for influenza hospitalizations until February 2020, after which the monthly counts dropped abruptly. This decrease in influenza-related hospitalizations coincided with the introduction of COVID-19-related measures (school closures, for instance). Only nine flu-associated hospitalizations were recorded in the October 2020 – April 2021 season. COVID-19-related hospitalizations ranged between 22 – 470 every month during the study period.

The flu-related hospitalization rate in children aged 0 – 4 years during 2017-18, 2018-19 seasons was similar to the annual rate of COVID-19 hospitalizations; however, it was higher in the 2019-20 season than the annual COVID-19 hospitalization rate. In those aged 5 – 11 years, the COVID-19 and influenza hospitalization rates were comparable, whereas, in adolescents (12 – 17 age group), hospitalization rates were lower in all influenza seasons than the COVID-19 hospitalization rate.

The median length of stay in the hospital was shorter for flu patients (2 days) than for COVID-19 cases (3 days). Pneumonia rate was higher in flu patients than COVID-19 cases, while children requiring ICU admission and mechanical ventilation support were fewer for influenza than COVID-19. The in-hospital mortality rate for flu and COVID-19 was similar.

Conclusions

Overall, the findings showed that the rate of influenza-associated hospitalizations was relatively lower in three seasons before the onset of the pandemic than the annual rate of COVID-19-associated hospitalizations and also noted age-wise differences.

Severe clinical outcome, in general, was comparable among children with COVID-19 and those with flu. The low rate of flu-related hospitalizations during the pandemic might be attributed to the COVID-19-related measures such as physical distancing, face masks, and virtual education. Notably, a typical seasonal pattern was observed for influenza, and such seasonality was absent for COVID-19, with infections spreading throughout the year.

Moreover, both influenza virus and SARS-CoV-2 infections can cause hospitalization with severe outcomes, and vaccinations against the two viruses can prevent disease and attenuate disease severity. According to the authors, preventive measures should be strictly adhered to and are essential to protecting children, particularly those ineligible for COVID-19 and flu vaccines.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Oropharyngeal microbiome profiled at admission is predictive of the need for respiratory support among COVID-19 patients. Image Credit: crystal light / Shutterstock.com

Could oropharyngeal microflora predict COVID-19 patients’ need for respiratory support?

by Medical Finance
July 5, 2022
0

In a recent study published on the preprint server medRxiv*, researchers from the United States identify a subset of oropharyngeal...

Study: Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses. Image Credit: ustas7777777 / Shutterstock.com

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

by Medical Finance
July 5, 2022
0

Scientists have worked at an unprecedented speed to develop effective vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),...

Study: Racial/Ethnic Disparities in the Observed COVID-19 Case Fatality Rate Among the U.S. Population. Image Credit: emojoez/Shutterstock

Differences in observed COVID-19 case fatality rates between different racial groups in the US

by Medical Finance
July 5, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers assessed the disparities in coronavirus disease 2019 (COVID-19) case...

Image Credit: Knowledge and experience of physicians during the COVID-19 Pandemic: A global cross-sectional study. Image Credit: PopTika/Shutterstock

Physicians’ knowledge, attitudes, and preventative practices regarding the COVID-19 pandemic

by Medical Finance
July 5, 2022
0

In a recent study posted to Research Square*, researchers conducted a global survey to assess the knowledge, attitudes, and practices...

Study: Protective and pathogenic role of humoral responses in COVID-19. Image Credit: CROCOTHERY/Shutterstock

Impact of humoral responses in COVID-19

by Medical Finance
July 5, 2022
0

A recent study published in the Journal of Microbiology discussed the function and impact of humoral immune responses in coronavirus...

Study: Severity of Covid-19 Cases in the Months of Predominance of the Alpha Variant and the Role of Vaccination. Image Credit: Kavic.C/Shutterstock

Severity of COVID-19 cases in the months of Alpha variant predominance compared to the Delta variant

by Medical Finance
July 5, 2022
0

In a recent study posted to the Research Square* preprint server under consideration at Scientific Reports, researchers conducted a prospective...

Next Post
Study: Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters. Image Credit: Natalia7/Shutterstock

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Study: SARS-CoV-2 genomic surveillance enables the identification of Delta/Omicron co-infections in Argentina. Image Credit: FOTOGRIN/Shutterstock

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States — FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021). Image Credit: Gorodenkoff/Shutterstock
    COVID-19-related hospitalizations in children below 18 years with influenza-associated hospitalizations
  • shutterstock 2127491597
    The trajectory of B-cell immunity six months after mRNA vaccination
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply